Cargando…

Expamers: a new technology to control T cell activation

T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particul...

Descripción completa

Detalles Bibliográficos
Autores principales: Poltorak, Mateusz P., Graef, Patricia, Tschulik, Claudia, Wagner, Michaela, Cletiu, Vlad, Dreher, Stefan, Borjan, Bojana, Fraessle, Simon P., Effenberger, Manuel, Turk, Martin, Busch, Dirk H., Plitzko, Juergen, Kugler, David G., Ragan, Seamus, Schmidt, Thomas, Stemberger, Christian, Germeroth, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575567/
https://www.ncbi.nlm.nih.gov/pubmed/33082362
http://dx.doi.org/10.1038/s41598-020-74595-8
_version_ 1783597834394664960
author Poltorak, Mateusz P.
Graef, Patricia
Tschulik, Claudia
Wagner, Michaela
Cletiu, Vlad
Dreher, Stefan
Borjan, Bojana
Fraessle, Simon P.
Effenberger, Manuel
Turk, Martin
Busch, Dirk H.
Plitzko, Juergen
Kugler, David G.
Ragan, Seamus
Schmidt, Thomas
Stemberger, Christian
Germeroth, Lothar
author_facet Poltorak, Mateusz P.
Graef, Patricia
Tschulik, Claudia
Wagner, Michaela
Cletiu, Vlad
Dreher, Stefan
Borjan, Bojana
Fraessle, Simon P.
Effenberger, Manuel
Turk, Martin
Busch, Dirk H.
Plitzko, Juergen
Kugler, David G.
Ragan, Seamus
Schmidt, Thomas
Stemberger, Christian
Germeroth, Lothar
author_sort Poltorak, Mateusz P.
collection PubMed
description T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particular not in a time dependent manner. Here, we describe a modular activation reagent called Expamers, which addresses these limitations. Expamers are versatile stimuli that are intended for research and clinical use. They are readily soluble and can be rapidly bound and removed from the cell surface, allowing nearly instantaneous initiation and termination of activation signal, respectively. Hence, Expamers enable precise regulation of T cell stimulation duration and provide promise of control over T cell profiles in future products. Expamers can be easily adopted to different T cell production formats and have the potential to increase efficacy of T cell immunotherapeutics.
format Online
Article
Text
id pubmed-7575567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75755672020-10-21 Expamers: a new technology to control T cell activation Poltorak, Mateusz P. Graef, Patricia Tschulik, Claudia Wagner, Michaela Cletiu, Vlad Dreher, Stefan Borjan, Bojana Fraessle, Simon P. Effenberger, Manuel Turk, Martin Busch, Dirk H. Plitzko, Juergen Kugler, David G. Ragan, Seamus Schmidt, Thomas Stemberger, Christian Germeroth, Lothar Sci Rep Article T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particular not in a time dependent manner. Here, we describe a modular activation reagent called Expamers, which addresses these limitations. Expamers are versatile stimuli that are intended for research and clinical use. They are readily soluble and can be rapidly bound and removed from the cell surface, allowing nearly instantaneous initiation and termination of activation signal, respectively. Hence, Expamers enable precise regulation of T cell stimulation duration and provide promise of control over T cell profiles in future products. Expamers can be easily adopted to different T cell production formats and have the potential to increase efficacy of T cell immunotherapeutics. Nature Publishing Group UK 2020-10-20 /pmc/articles/PMC7575567/ /pubmed/33082362 http://dx.doi.org/10.1038/s41598-020-74595-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Poltorak, Mateusz P.
Graef, Patricia
Tschulik, Claudia
Wagner, Michaela
Cletiu, Vlad
Dreher, Stefan
Borjan, Bojana
Fraessle, Simon P.
Effenberger, Manuel
Turk, Martin
Busch, Dirk H.
Plitzko, Juergen
Kugler, David G.
Ragan, Seamus
Schmidt, Thomas
Stemberger, Christian
Germeroth, Lothar
Expamers: a new technology to control T cell activation
title Expamers: a new technology to control T cell activation
title_full Expamers: a new technology to control T cell activation
title_fullStr Expamers: a new technology to control T cell activation
title_full_unstemmed Expamers: a new technology to control T cell activation
title_short Expamers: a new technology to control T cell activation
title_sort expamers: a new technology to control t cell activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575567/
https://www.ncbi.nlm.nih.gov/pubmed/33082362
http://dx.doi.org/10.1038/s41598-020-74595-8
work_keys_str_mv AT poltorakmateuszp expamersanewtechnologytocontroltcellactivation
AT graefpatricia expamersanewtechnologytocontroltcellactivation
AT tschulikclaudia expamersanewtechnologytocontroltcellactivation
AT wagnermichaela expamersanewtechnologytocontroltcellactivation
AT cletiuvlad expamersanewtechnologytocontroltcellactivation
AT dreherstefan expamersanewtechnologytocontroltcellactivation
AT borjanbojana expamersanewtechnologytocontroltcellactivation
AT fraesslesimonp expamersanewtechnologytocontroltcellactivation
AT effenbergermanuel expamersanewtechnologytocontroltcellactivation
AT turkmartin expamersanewtechnologytocontroltcellactivation
AT buschdirkh expamersanewtechnologytocontroltcellactivation
AT plitzkojuergen expamersanewtechnologytocontroltcellactivation
AT kuglerdavidg expamersanewtechnologytocontroltcellactivation
AT raganseamus expamersanewtechnologytocontroltcellactivation
AT schmidtthomas expamersanewtechnologytocontroltcellactivation
AT stembergerchristian expamersanewtechnologytocontroltcellactivation
AT germerothlothar expamersanewtechnologytocontroltcellactivation